10-Q//Quarterly update
NUVELO INC 10-Q
Accession 0001193125-05-160978
$ORKACIK 0000907654operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 5:38 PM ET
Size
2.2 MB
Accession
0001193125-05-160978
Documents
- 10-Qd10q.htmPrimary
FORM 10-Q
- EX-10.5dex105.htm
AMENDED EMPLOYEE STOCK PURCHASE PLAN
- EX-10.41dex1041.htm
NUVELO, INC. 2004 EQUITY INCENTIVE PLAN, AS AMENDED
- EX-10.55dex1055.htm
DEVELOPMENT AND VALIDATION AGREEMENT
- EX-31.1dex311.htm
CERTIFICATE OF CEO PURSUANT TO SECTION 302
- EX-31.2dex312.htm
CERTIFICATE OF CFO PURSUANT TO SECTION 302
- EX-32.1dex321.htm
CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906
- GRAPHICg17073img01.jpg
GRAPHIC
- GRAPHICg17073img02.jpg
GRAPHIC
- GRAPHICg17073img03.jpg
GRAPHIC
Issuer
Oruka Therapeutics, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 10-Q
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 5:38 PM ET
- Size
- 2.2 MB